Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
CNY 3.13
(-3.4%)
CNY 3.13
(-3.4%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 689.53 Million CNY | -27.55% |
| 2022 | 951.77 Million CNY | -2.32% |
| 2021 | 974.42 Million CNY | -3.96% |
| 2020 | 1.01 Billion CNY | -3.09% |
| 2019 | 1.04 Billion CNY | 296.87% |
| 2018 | 263.8 Million CNY | 559.5% |
| 2017 | 40 Million CNY | 0.0% |
| 2016 | - CNY | -100.0% |
| 2015 | 752.36 Million CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 30 Million CNY | 50.0% |
| 2012 | 20 Million CNY | -65.52% |
| 2011 | 58 Million CNY | -14.71% |
| 2010 | 68 Million CNY | -48.13% |
| 2009 | 131.1 Million CNY | -0.76% |
| 2008 | 132.1 Million CNY | 0.0% |
| 2007 | 132.1 Million CNY | 26.9% |
| 2006 | 104.1 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 645.56 Million CNY | 1.42% |
| 2024 Q3 | 606.59 Million CNY | -6.04% |
| 2024 Q1 | 636.52 Million CNY | -7.69% |
| 2023 Q3 | 861.54 Million CNY | -10.34% |
| 2023 FY | 689.53 Million CNY | -27.55% |
| 2023 Q1 | 949.94 Million CNY | -0.19% |
| 2023 Q2 | 960.94 Million CNY | 1.16% |
| 2023 Q4 | 689.53 Million CNY | -19.97% |
| 2022 Q4 | 951.77 Million CNY | -1.84% |
| 2022 Q2 | 908.07 Million CNY | -6.93% |
| 2022 Q1 | 975.65 Million CNY | 0.13% |
| 2022 FY | 951.77 Million CNY | -2.32% |
| 2022 Q3 | 969.62 Million CNY | 6.78% |
| 2021 Q2 | 1 Billion CNY | -2.32% |
| 2021 Q3 | 1.01 Billion CNY | 1.17% |
| 2021 Q4 | 974.42 Million CNY | -3.85% |
| 2021 FY | 974.42 Million CNY | -3.96% |
| 2021 Q1 | 1.02 Billion CNY | 1.08% |
| 2020 Q3 | 1.04 Billion CNY | 0.96% |
| 2020 Q4 | 1.01 Billion CNY | -2.93% |
| 2020 Q2 | 1.03 Billion CNY | -2.02% |
| 2020 FY | 1.01 Billion CNY | -3.09% |
| 2020 Q1 | 1.05 Billion CNY | 0.92% |
| 2019 Q3 | 1.1 Billion CNY | 0.9% |
| 2019 FY | 1.04 Billion CNY | 296.87% |
| 2019 Q1 | 421.8 Million CNY | 59.89% |
| 2019 Q2 | 1.09 Billion CNY | 159.83% |
| 2019 Q4 | 1.04 Billion CNY | -5.32% |
| 2018 Q1 | 19.9 Million CNY | -50.25% |
| 2018 FY | 263.8 Million CNY | 559.5% |
| 2018 Q4 | 263.8 Million CNY | 7.94% |
| 2018 Q3 | 244.4 Million CNY | 8.91% |
| 2018 Q2 | 224.4 Million CNY | 1027.64% |
| 2017 Q2 | 40 Million CNY | 100.0% |
| 2017 FY | 40 Million CNY | 0.0% |
| 2017 Q1 | 20 Million CNY | 0.0% |
| 2017 Q4 | 40 Million CNY | 0.0% |
| 2017 Q3 | 40 Million CNY | 0.0% |
| 2016 Q3 | 220.05 Million CNY | -70.26% |
| 2016 Q4 | - CNY | -100.0% |
| 2016 Q1 | 740.21 Million CNY | -1.61% |
| 2016 FY | - CNY | -100.0% |
| 2016 Q2 | 739.99 Million CNY | -0.03% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 FY | 752.36 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 752.36 Million CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q4 | 30 Million CNY | 200.0% |
| 2013 Q1 | 20 Million CNY | 0.0% |
| 2013 Q3 | 10 Million CNY | 0.0% |
| 2013 Q2 | 10 Million CNY | -50.0% |
| 2013 FY | 30 Million CNY | 50.0% |
| 2012 Q4 | 20 Million CNY | -61.58% |
| 2012 FY | 20 Million CNY | -65.52% |
| 2012 Q3 | 52.06 Million CNY | -25.63% |
| 2012 Q2 | 70 Million CNY | 75.0% |
| 2012 Q1 | 40 Million CNY | -31.03% |
| 2011 Q2 | 58 Million CNY | -14.71% |
| 2011 Q1 | 68 Million CNY | 0.0% |
| 2011 Q3 | 28 Million CNY | -51.72% |
| 2011 FY | 58 Million CNY | -14.71% |
| 2011 Q4 | 58 Million CNY | 107.14% |
| 2010 Q3 | 80 Million CNY | -11.11% |
| 2010 FY | 68 Million CNY | -48.13% |
| 2010 Q4 | 68 Million CNY | -15.0% |
| 2010 Q2 | 90 Million CNY | 0.0% |
| 2010 Q1 | 90 Million CNY | -31.35% |
| 2009 FY | 131.1 Million CNY | -0.76% |
| 2009 Q4 | 131.1 Million CNY | 0.0% |
| 2009 Q2 | 131.1 Million CNY | 0.0% |
| 2008 FY | 132.1 Million CNY | 0.0% |
| 2007 FY | 132.1 Million CNY | 26.9% |
| 2006 FY | 104.1 Million CNY | 0.0% |